Skip to main content
Erschienen in: International Urology and Nephrology 7/2016

27.04.2016 | Nephrology - Original Paper

Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis

verfasst von: Binnur Bagci, Gokhan Bagci, Can Huzmeli, Ilhan Sezgin, Ozturk Ozdemir

Erschienen in: International Urology and Nephrology | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to investigate the associations of fractalkine receptor (CX3CR1) V249I, T280M and CCR5-59029 A/G gene polymorphisms in chronic renal failure (CRF) subjects undergoing hemodialysis and to evaluate possible associations of these polymorphisms with hypertension (HT), diabetes mellitus (DM) and atherosclerosis (AS).

Methods

A total of 225 CRF subjects undergoing hemodialysis and 201 healthy controls were enrolled in the study. CRF subjects were divided into three major subgroups according to comorbidities including HT (n = 127), DM (n = 65) and AS (n = 33). Genotyping was done using polymerase chain reaction–restriction fragment length polymorphism method.

Results

The II genotype and I allele frequencies of CX3CR1 V249I polymorphism were found significantly more frequent in CRF subjects, CRF subjects with DM and CRF subjects with AS compared with controls (p < 0.05 for all comparisons). G allele frequency of CCR5 polymorphism was found significantly more prevalent in CRF subjects with DM than that of controls. Further, GG genotype and G allele frequencies of CCR5 polymorphism were significantly more prevalent in CRF subjects with AS compared with controls (p < 0.05). We also explored these polymorphisms among CRF subjects with and without following comorbidities: HT, DM, AS. We found significant association between CRF subjects with HT and without HT in terms of genotype and allele frequencies of V249I polymorphism (p < 0.05). CX3CR1 T280M polymorphism was not found significantly different in none of the comparisons.

Conclusion

These data demonstrate possible associations between CX3CR1 V249I and CCR5-59029 A/G polymorphisms and/or HT, DM and AS in CRF subjects.
Literatur
2.
Zurück zum Zitat Yilmaz M, Sari I, Bagci B, Gumus E, Ozdemir O (2015) Aldosterone synthase CYP11B2 gene promoter polymorphism in a Turkish population with chronic kidney disease. Iran J Kidney Dis 9(3):209–214PubMed Yilmaz M, Sari I, Bagci B, Gumus E, Ozdemir O (2015) Aldosterone synthase CYP11B2 gene promoter polymorphism in a Turkish population with chronic kidney disease. Iran J Kidney Dis 9(3):209–214PubMed
3.
Zurück zum Zitat Süleymanlar G, Utaş C, Arinsoy T et al (2011) A population-based survey of Chronic REnal Disease In Turkey–the CREDIT study. Nephrol Dial Transpl 26(6):1862–1871CrossRef Süleymanlar G, Utaş C, Arinsoy T et al (2011) A population-based survey of Chronic REnal Disease In Turkey–the CREDIT study. Nephrol Dial Transpl 26(6):1862–1871CrossRef
4.
Zurück zum Zitat Silverstein DM (2009) Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24(8):1445–1452CrossRefPubMed Silverstein DM (2009) Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24(8):1445–1452CrossRefPubMed
6.
Zurück zum Zitat Segerer S, Nelson PJ, Schlöndorff D (2000) Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11(1):152–176PubMed Segerer S, Nelson PJ, Schlöndorff D (2000) Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 11(1):152–176PubMed
7.
Zurück zum Zitat Zernecke A, Shagdarsuren E, Weber C (2008) Chemokines in atherosclerosis an update. Arterioscler Thromb Vasc Biol 28(11):1897–1908CrossRefPubMed Zernecke A, Shagdarsuren E, Weber C (2008) Chemokines in atherosclerosis an update. Arterioscler Thromb Vasc Biol 28(11):1897–1908CrossRefPubMed
8.
Zurück zum Zitat Chakravorty SJ, Cockwell P, Girdlestone J, Brooks CJ, Savage COS (2002) Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clin Exp Immunol 129(1):150–159CrossRefPubMedPubMedCentral Chakravorty SJ, Cockwell P, Girdlestone J, Brooks CJ, Savage COS (2002) Fractalkine expression on human renal tubular epithelial cells: potential role in mononuclear cell adhesion. Clin Exp Immunol 129(1):150–159CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO (2002) Fractalkine expression in human renal inflammation. J Pathol 196(1):85–90CrossRefPubMed Cockwell P, Chakravorty SJ, Girdlestone J, Savage CO (2002) Fractalkine expression in human renal inflammation. J Pathol 196(1):85–90CrossRefPubMed
10.
Zurück zum Zitat Segerer S, Hughes E, Hudkins KL, Mack M, Goodpaster T, Alpers CE (2002) Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 62(2):488–495CrossRefPubMed Segerer S, Hughes E, Hudkins KL, Mack M, Goodpaster T, Alpers CE (2002) Expression of the fractalkine receptor (CX3CR1) in human kidney diseases. Kidney Int 62(2):488–495CrossRefPubMed
11.
Zurück zum Zitat Segerer S, Mack M, Regele H, Kerjaschki D, Schlöndorff D (1999) Expression of the CC chemokine receptor 5 in human kidney diseases. Kidney Int 56(1):52–64CrossRefPubMed Segerer S, Mack M, Regele H, Kerjaschki D, Schlöndorff D (1999) Expression of the CC chemokine receptor 5 in human kidney diseases. Kidney Int 56(1):52–64CrossRefPubMed
12.
Zurück zum Zitat Anders HJ, Vielhauer V, Schlöndorff D (2003) Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63(2):401–415CrossRefPubMed Anders HJ, Vielhauer V, Schlöndorff D (2003) Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63(2):401–415CrossRefPubMed
13.
Zurück zum Zitat Fischereder M, Luckow B, Hocher B et al (2001) CC chemokine receptor 5 and renal-transplant survival. Lancet 357(9270):1758–1761CrossRefPubMed Fischereder M, Luckow B, Hocher B et al (2001) CC chemokine receptor 5 and renal-transplant survival. Lancet 357(9270):1758–1761CrossRefPubMed
14.
Zurück zum Zitat Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C (2011) Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. Obesity 19(1):222–227CrossRefPubMed Sirois-Gagnon D, Chamberland A, Perron S, Brisson D, Gaudet D, Laprise C (2011) Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity. Obesity 19(1):222–227CrossRefPubMed
15.
Zurück zum Zitat Ting KH, Ueng KC, Chiang WL, Chou YE, Yang SF, Wang PH (2015) Relationship of genetic polymorphisms of the chemokine, CCL5, and its receptor, CCR5, with coronary artery disease in Taiwan. Evid Based Complement Altern Med 2015:851683CrossRef Ting KH, Ueng KC, Chiang WL, Chou YE, Yang SF, Wang PH (2015) Relationship of genetic polymorphisms of the chemokine, CCL5, and its receptor, CCR5, with coronary artery disease in Taiwan. Evid Based Complement Altern Med 2015:851683CrossRef
16.
17.
Zurück zum Zitat Abdi R, Huong TTB, Sahagun-Ruiz A et al (2002) Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13(3):754–758PubMed Abdi R, Huong TTB, Sahagun-Ruiz A et al (2002) Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 13(3):754–758PubMed
18.
Zurück zum Zitat American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55–S60CrossRef American Diabetes Association (2008) Diagnosis and classification of diabetes mellitus. Diabetes Care 31(Suppl 1):S55–S60CrossRef
19.
Zurück zum Zitat Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28(12):1462–1536PubMed Mancia G, De Backer G, Dominiczak A et al (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28(12):1462–1536PubMed
20.
Zurück zum Zitat Eis V, Vielhauer V, Anders HJ (2004) Targeting the chemokine network in renal inflammation. Arch Immunol Ther Exp (Warsz) 52(3):164–172 Eis V, Vielhauer V, Anders HJ (2004) Targeting the chemokine network in renal inflammation. Arch Immunol Ther Exp (Warsz) 52(3):164–172
21.
Zurück zum Zitat Bagci B, Bagci G, Candan F, Ozdemir O, Sezgin I (2015) The protective effect of MCP-1-2518 A > G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis. Int Urol Nephrol 47(3):551–556CrossRefPubMed Bagci B, Bagci G, Candan F, Ozdemir O, Sezgin I (2015) The protective effect of MCP-1-2518 A > G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis. Int Urol Nephrol 47(3):551–556CrossRefPubMed
22.
Zurück zum Zitat Sezgin I, Koksal B, Bagci G, Kurtulgan HK, Ozdemir O (2011) CCR2 polymorphism in chronic renal failure patients requiring long-term hemodialysis. Intern Med 50(21):2457–2461CrossRefPubMed Sezgin I, Koksal B, Bagci G, Kurtulgan HK, Ozdemir O (2011) CCR2 polymorphism in chronic renal failure patients requiring long-term hemodialysis. Intern Med 50(21):2457–2461CrossRefPubMed
23.
Zurück zum Zitat Engel DR, Krause TA, Snelgrove SL et al (2015) CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages. J Immunol 194(4):1628–1638CrossRefPubMed Engel DR, Krause TA, Snelgrove SL et al (2015) CX3CR1 reduces kidney fibrosis by inhibiting local proliferation of profibrotic macrophages. J Immunol 194(4):1628–1638CrossRefPubMed
25.
Zurück zum Zitat Courivaud C, Bamoulid J, Loupy A et al (2013) Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantation. Transplantation 95(5):728–732CrossRefPubMed Courivaud C, Bamoulid J, Loupy A et al (2013) Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantation. Transplantation 95(5):728–732CrossRefPubMed
26.
Zurück zum Zitat Borkar M, Tripathi G, Sharma RK, Sankhwar SN, Agrawal S (2011) Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease. Inflamm Res 60(4):399–407CrossRefPubMed Borkar M, Tripathi G, Sharma RK, Sankhwar SN, Agrawal S (2011) Chemokine (CCR) and fractalkine (CX3CR) receptors and end stage renal disease. Inflamm Res 60(4):399–407CrossRefPubMed
27.
Zurück zum Zitat Hoffmann U, Bergler T, Segerer S et al (2010) Impact of chemokine receptor CX3CR1 in human renal allograft rejection. Transpl Immunol 23(4):204–208CrossRefPubMed Hoffmann U, Bergler T, Segerer S et al (2010) Impact of chemokine receptor CX3CR1 in human renal allograft rejection. Transpl Immunol 23(4):204–208CrossRefPubMed
28.
Zurück zum Zitat Cao G, Lu Y, Gao R et al (2006) Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection. Transpl Proc 38(7):1998–2000CrossRef Cao G, Lu Y, Gao R et al (2006) Expression of fractalkine, CX3CR1, and vascular endothelial growth factor in human chronic renal allograft rejection. Transpl Proc 38(7):1998–2000CrossRef
29.
Zurück zum Zitat Dabrowska-Zamojcin E, Dziedziejko V, Safranow K, Kurzawski M, Domanski L, Pawlik A (2015) Association between the CX3CR1 gene V249I polymorphism and delayed kidney allograft function. Transpl Immunol 32(3):172–174CrossRefPubMed Dabrowska-Zamojcin E, Dziedziejko V, Safranow K, Kurzawski M, Domanski L, Pawlik A (2015) Association between the CX3CR1 gene V249I polymorphism and delayed kidney allograft function. Transpl Immunol 32(3):172–174CrossRefPubMed
30.
Zurück zum Zitat Ozdemir O, Kayatas M, Cetinkaya S et al (2015) Bcıı–RFLP profiles for serum amiloid A1 and mutated MEFV gene prevalence in chronic renal failure patients requiring long-term hemodialysis. Ren Fail 37(2):292–296CrossRefPubMed Ozdemir O, Kayatas M, Cetinkaya S et al (2015) Bcıı–RFLP profiles for serum amiloid A1 and mutated MEFV gene prevalence in chronic renal failure patients requiring long-term hemodialysis. Ren Fail 37(2):292–296CrossRefPubMed
31.
32.
Zurück zum Zitat Losito A, Kalidas K, Santoni S, Jeffery S (2003) Association of interleukin-6-174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 64(2):616–622CrossRefPubMed Losito A, Kalidas K, Santoni S, Jeffery S (2003) Association of interleukin-6-174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 64(2):616–622CrossRefPubMed
33.
Zurück zum Zitat Yadav AK, Lal A, Jha V (2011) Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease. J Atheroscler Thromb 18(11):958–965CrossRefPubMed Yadav AK, Lal A, Jha V (2011) Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease. J Atheroscler Thromb 18(11):958–965CrossRefPubMed
34.
Zurück zum Zitat Wu J, Yin RX, Lin QZ et al (2014) Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis. Dis Markers 2014:913678CrossRefPubMedPubMedCentral Wu J, Yin RX, Lin QZ et al (2014) Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis. Dis Markers 2014:913678CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Mogensen CE (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31(2):673–689CrossRefPubMed Mogensen CE (1987) Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int 31(2):673–689CrossRefPubMed
36.
Zurück zum Zitat Zakaria E, Al-Rawi H, Ghanem NS, Elsayed NM, Rashed A (2013) Fractalkine in type 2 Egyptian diabetics with and without nephropathy. Egypt J Intern Med 25(3):133–136 Zakaria E, Al-Rawi H, Ghanem NS, Elsayed NM, Rashed A (2013) Fractalkine in type 2 Egyptian diabetics with and without nephropathy. Egypt J Intern Med 25(3):133–136
37.
Zurück zum Zitat Song KH, Park J, Park JH, Natarajan R, Ha H (2013) Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice. Diabetologia 56(7):1661–1669CrossRefPubMedPubMedCentral Song KH, Park J, Park JH, Natarajan R, Ha H (2013) Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice. Diabetologia 56(7):1661–1669CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Kikuchi Y, Ikee R, Hemmi N et al (2004) Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys. Nephron Exp Nephrol 97(1):e17–e25CrossRefPubMed Kikuchi Y, Ikee R, Hemmi N et al (2004) Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys. Nephron Exp Nephrol 97(1):e17–e25CrossRefPubMed
39.
Zurück zum Zitat Fyhrquist F, Metsärinne K, Tikkanen I (1995) Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Hum Hypertens 9(Suppl 5):S19–S24PubMed Fyhrquist F, Metsärinne K, Tikkanen I (1995) Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Hum Hypertens 9(Suppl 5):S19–S24PubMed
40.
Zurück zum Zitat Rius C, Piqueras L, González-Navarro H et al (2013) Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II. Arterioscler Thromb Vasc Biol 33(1):96–104CrossRefPubMed Rius C, Piqueras L, González-Navarro H et al (2013) Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II. Arterioscler Thromb Vasc Biol 33(1):96–104CrossRefPubMed
41.
Zurück zum Zitat Martynowicz H, Janus A, Nowacki D, Mazur G (2014) The role of chemokines in hypertension. Adv Clin Exp Med 23(3):319–325CrossRefPubMed Martynowicz H, Janus A, Nowacki D, Mazur G (2014) The role of chemokines in hypertension. Adv Clin Exp Med 23(3):319–325CrossRefPubMed
42.
Zurück zum Zitat Schäfer A, Schulz C, Fraccarollo D et al (2007) The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler Thromb Vasc Biol 27(1):55–62CrossRefPubMed Schäfer A, Schulz C, Fraccarollo D et al (2007) The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler Thromb Vasc Biol 27(1):55–62CrossRefPubMed
43.
Zurück zum Zitat Marasini B, Cossutta R, Selmi C et al (2005) Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 12(4):275–279CrossRefPubMedPubMedCentral Marasini B, Cossutta R, Selmi C et al (2005) Polymorphism of the fractalkine receptor CX3CR1 and systemic sclerosis-associated pulmonary arterial hypertension. Clin Dev Immunol 12(4):275–279CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Turner JE, Paust HJ, Steinmetz OM et al (2008) CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol 181(9):6546–6556CrossRefPubMed Turner JE, Paust HJ, Steinmetz OM et al (2008) CCR5 deficiency aggravates crescentic glomerulonephritis in mice. J Immunol 181(9):6546–6556CrossRefPubMed
46.
Zurück zum Zitat Cha RH, Yang SH, Kim HS et al (2009) Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5. Nephrol Dial Transpl 24(9):2919–2925CrossRef Cha RH, Yang SH, Kim HS et al (2009) Genetic interactions between the donor and the recipient for susceptibility to acute rejection in kidney transplantation: polymorphisms of CCR5. Nephrol Dial Transpl 24(9):2919–2925CrossRef
47.
Zurück zum Zitat Krichen H, Khazen D, Sfar I et al (2011) Genetic polymorphisms of inflammatory molecules in Tunisian kidney transplantation. Transpl Proc 43(2):433–436CrossRef Krichen H, Khazen D, Sfar I et al (2011) Genetic polymorphisms of inflammatory molecules in Tunisian kidney transplantation. Transpl Proc 43(2):433–436CrossRef
48.
Zurück zum Zitat Hoffmann S, Park J, Jacobson LM et al (2004) Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 66(4):1686–1693CrossRefPubMed Hoffmann S, Park J, Jacobson LM et al (2004) Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 66(4):1686–1693CrossRefPubMed
49.
Zurück zum Zitat Yadav AK, Kumar V, Dutta P, Bhansali A, Jha V (2014) Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney disease in north Indian individuals with type 2 diabetes. J Diabetes 6(6):547–555CrossRefPubMed Yadav AK, Kumar V, Dutta P, Bhansali A, Jha V (2014) Variations in CCR5, but not HFE, ELMO1, or SLC12A3, are associated with susceptibility to kidney disease in north Indian individuals with type 2 diabetes. J Diabetes 6(6):547–555CrossRefPubMed
50.
Zurück zum Zitat Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS (2005) Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes 54(11):3331–3335CrossRefPubMed Mlynarski WM, Placha GP, Wolkow PP, Bochenski JP, Warram JH, Krolewski AS (2005) Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect. Diabetes 54(11):3331–3335CrossRefPubMed
51.
Zurück zum Zitat Prasad P, Tiwari AK, Kumar KP et al (2007) Association of TGFβ1, TNFα, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 8(1):20CrossRefPubMedPubMedCentral Prasad P, Tiwari AK, Kumar KP et al (2007) Association of TGFβ1, TNFα, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 8(1):20CrossRefPubMedPubMedCentral
Metadaten
Titel
Associations of fractalkine receptor (CX3CR1) and CCR5 gene variants with hypertension, diabetes and atherosclerosis in chronic renal failure patients undergoing hemodialysis
verfasst von
Binnur Bagci
Gokhan Bagci
Can Huzmeli
Ilhan Sezgin
Ozturk Ozdemir
Publikationsdatum
27.04.2016
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 7/2016
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1293-0

Weitere Artikel der Ausgabe 7/2016

International Urology and Nephrology 7/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.